Analyst Price Targets — EMBCV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 16, 2022 7:51 am | — | Morgan Stanley | $36.00 | $33.33 | Benzinga | Morgan Stanley Maintains Equal-Weight on Embecta, Raises Price Target to $36 |
Latest News for EMBCV
New York, New York--(Newsfile Corp. - June 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.
NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 17,…
New York, New York--(Newsfile Corp. - June 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for EMBCV.
Senate Trading
No Senate trades found for EMBCV.
U.S. House Trading
No House trades found for EMBCV.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.